AI | pharmaphorum

AI

News

BenevolentAI and charities to seek macular degeneration cure

BenevolentAI and a group of UK sight loss charities have launched a new partnership to use the firm’s AI-powered drug discovery to find treatments and a potential cure for age-related macul

Views & Analysis

Solving the Big Data problem in pharma innovation

The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue?

Views & Analysis

Doctor and robot connected with a wire, EPS 8 vector illustration

Do physicians actually care about healthcare's AI revolution...

Ahead of his talk at EyeforPharma Barcelona next week, Medscape’s Ben Greenberg talks to pharmaphorum about the hype surrounding technology, and offers ideas about how to identify meaningful innovation.

Cancer

AI specialists join Genomics England’s drug discovery allian...

Lantern Pharma, a pharma company which uses artificial intelligence to develop shelved oncology drugs has joined Genomics England’s groundbreaking industry partnership.

Views & Analysis

Novartis' Basel HQ: the company is looking for more blockbusters to lift revenues

Jay Bradner: leading Novartis into age of digitally-enabled ...

Jay Bradner, head of Novartis’ drug discovery, talks to pharmaphorum about the firm’s drive to transform itself into 'a medicine and data science company'.

Views & Analysis